Articles by Sarika Jain, MD
Management of Metastatic HER2-Positive Breast Cancer: Where Are We and Where Do We Go From Here?
ByCesar Augusto Santa-Maria, MD,Lauren Nye, MD,Martin B. Mutonga,Sarika Jain, MD,William J Gradishar, MD, FASCO, FACP This review will summarize the current standard of care; key issues that arise when treating patients with HER2-positive disease; and developments in novel therapeutics, including small-molecule inhibitors, nanoparticles, immunotherapy, and agents targeting resistance pathways.
Here, we provide an in-depth review of the current evidence for the addition of ovarian suppression to adjuvant endocrine therapy, and we offer recommendations for clinical management.
